PRIMARY ALDOSTERONISM (PA) is characterized by overproduction of the mineralocorticoid hormone aldosterone by adrenal glands. According to recent reports, it appears to be the most common cause of secondary persistent hypertension, and may account for about 8~13% of unselected hypertensives [1] and as high as 20% of resistant hypertensives [2, 3] . The inappropriately high production of aldosterone causes suppression of plasma renin, sodium retention, hypertension, cardiovascular damage, and potassium excretion [4] . Elevated blood pressure combined with the proinflammatory and profibrotic effects of aldosterone To date, although the genetic basis of familial hyperaldosteronism has been more clearly, the exact pathogenesis of sporadic forms of the disease remains unknown. Among a number of studied susceptibility genes, the aldosterone synthase gene (CYP11B2) is the most commonly studied. The CYP11B2 gene situates on chromosome 8q24.3 and encodes aldosterone synthase, which is the key rate-limiting enzyme for the final stage of aldosterone synthesis pathway and pri-
excess can therefore result in an increased incidence of cerebrovascular [5] , cardiovascular [6] , renal [7] , metabolic [8] and psychiatric [9] complications.
To date, although the genetic basis of familial hyperaldosteronism has been more clearly, the exact pathogenesis of sporadic forms of the disease remains unknown. Among a number of studied susceptibility genes, the aldosterone synthase gene (CYP11B2) is the most commonly studied. The CYP11B2 gene situates on chromosome 8q24.3 and encodes aldosterone synthase, which is the key rate-limiting enzyme for the final stage of aldosterone synthesis pathway and pri-to calculate odds ratio (OR) and 95% confidence interval (CI); (4) written in English or Chinese. In addition, we communicated with the authors of eligible studies when pertinent data were not described.
From each study, the following information was obtained: (1) name of the first author; (2) year of publication; (3) country of origin; (4) source of control subjects; (5) diagnostic criteria of PA; (6) numbers of cases and controls; (7) genotyping methods; (8) types of diseases; (9) numbers of genotypes for two polymorphisms in cases and controls. If more than one study was published on the possible of same case populations, only the most recent and complete study was used. All data were extracted independently by two investigators (Minyue Jia and Hong Zhang) and consensus was achieved for all data.
Statistical analysis
Firstly, the Hardy-Weinberg equilibrium (HWE) in the controls for each study was assessed using chisquare goodness of fit test and P<0.05 was considered as significant disequilibrium. The strength of the association between CYP11B2 polymorphisms and PA was estimated by calculating a pooled OR and 95%CI. For each polymorphism, four different models were calculated: (1) homozygote comparison; (2) heterozygote vs wild homozygote; (3) dominant model; (4) recessive model. The stratified analyses were also carried out by type of PA , source of controls and country. The heterogeneity between the studies was assessed by the Chisquare-test based Cochrane Q-test [11] . And the I 2 statistic to quantify the proportion of the total variation due to heterogeneity was also calculated [12] . A P>0.10 for the Q-test indicated a lack of heterogeneity among the studies, then the pooled OR estimate of each study was calculated by the fixed-effects model (the Mantel-Haenszel method). Otherwise, the random-effects model (the DerSimonian and Laird method) was used. Publication bias was statistically assessed by funnel plot and Egger's weighted regression method [13] . An asymmetric plot or the P value of Egger's test <0.05 was considered statistically significant. Sensitivity analysis was performed by removing the studies not in HWE to assess the stability of the results. The statistical analyses were performed using STATA version 12.0 software. All the P values are two-tailed. marily expressed in the zona glomerulosa of adrenal cortex. Two common polymorphisms of CYP11B2 have been studied to explore their associations with PA: (i) a T-344C mutation (rs1799998); (ii) a A2718G mutation (rs4539) [10] . The biological effects of these two polymorphisms and their associations with PA are still unclear. The first polymorphism, T-344C, is localized in the promoter region of CYP11B2 and disrupts to a putative recognition site for the steroidogenic transcription factor 1 (SF-1). The second polymorphism, A2718G, also known as substitution from Lys to Arg in the coding region of the gene does not affect aldosterone synthesis in vitro [10] .
So far, a number of studies have been made to investigate the association between these two polymorphisms in CYP11B2 gene and the risk of PA, but the results were controversial. There may be many reasons for discrepancies, such as limited samples, insufficient statistical power, different recruitment procedures, as well as differences in the genetic and environmental backgrounds. Meta-analysis is a useful method to overcome the disadvantages of individual studies by producing a pooled effect estimate with enhanced precision. Thus, we carried out a meta-analysis to investigate the association of T-344C and A2718G polymorphisms in CYP11B2 gene with PA risk.
Materials and Methods

Search methods for identification of studies
The relevant studies were identified through a search of PubMed, Embase, ISI Web of Knowledge, VIP Database for Chinese Technical Periodicals, Chinese Wanfang and Chinese National Knowledge Infrastructure (CNKI) databases until November 2012.
The search strategy involved using combinations of the following key words: 'primary aldosteronism,' 'hyperaldosteronism,' 'Conn syndrome,' 'aldosteroneproducing adenoma,' 'aldosterone synthase gene,' and 'CYP11B2.' Associated references of retrieved articles and reviews were hand-searched to find additionally eligible studies.
Inclusion criteria and data extraction
The studies included in the meta-analysis must meet all the following inclusion criteria: (1) evaluating the association between T-344C or A2718G polymorphism and risk of PA (not including familial hyperaldosteronism); (2) case-control study design; (3) enough data gote comparison (CC vs TT) and recessive model (CC vs CT+TT), no significant association was detected.
The main results of the meta-analyses and the heterogeneity tests were shown in Table 2 and Fig. 2 .
Considering the fact that the idiopathic hyperaldosteronism (IHA) and aldosterone-producing adenoma (APA) might have different genetic basis, a subgroup analysis was conducted according to type of PA. As reflected in Table 1 Table 2) .
Further stratified analyses were performed by controls. Three studies provided data for IHA compared with normotensives (153 cases and 370 controls) and four studies for essential hypertensives (200 cases and
Results
Characteristics of studies
769 potentially relevant studies were identified after the initial search. After an extensive selection according to the inclusion criteria (Fig. 1) , seven studies [14] [15] [16] [17] [18] [19] [20] (621 cases and 1027 controls) on T-344C polymorphism, three studies [18, 20, 21] (327 cases and 336 controls) on A2718G polymorphism were included for meta-analyses. Detailed characteristics of the eight eligible studies and the genotype distributions of the two tested polymorphisms were listed in Table 1 . The genotype distributions in the controls of all studies did not deviate significantly from HWE except two studies [14, 20] . Blinding of laboratory personnel to pertinent characteristics of the samples, donor subjects, and hypotheses was not reported in any of the studies.
Quantitative data synthesis
T-344C polymorphism
The results from the meta-analyses indicated statistically significant association between T-344C polymorphism and PA risk under two genetic models (CT vs TT, OR=0.608, 95%CI=0.478~0.772; CC+CT vs TT, OR=0.662, 95%CI=0.526~0.832). But under homozy- were shown in Table 2 . As to APA, there were one study from Japan and three studies from China. Due to the limited study number and sample size, stratified analysis by country in APA was not performed. (Table 4) .
A2718G polymorphism
Sensitivity analysis
Sensitivity analysis was performed by excluding the studies with controls inconsistent with HWE. The results were similar to those of the primary analyses. But significant association between T-344C polymorphism and susceptibility to IHA was identi-545 controls). Significant differences were found under all genetic models for IHA compared with normotensives. And for IHA compared with essential hypertensives, two models produced significant association (CT vs TT, OR=0.519, 95%CI=0.360~0.748; CC+CT vs TT, OR=0.527, 95%CI=0.370~0.751) ( Table 3 ). As only one study about the T-344C polymorphism and APA was included when limited the controls to normotensives or essential hypertensives, an additional subgroup analysis based on source of controls for APA was not performed.
As the prevalence of T-344C polymorphism in different countries may be various, the subgroup analysis by country was also performed. All the IHAs in the included five studies were from Italy and China (three studies from Italy and two from China 
Publication bias
Funnel plot and Egger's test were performed to access the publication bias of literatures. No publication bias was detected for the association between T-344C polymorphism and PA risk (all P>0.05, data not shown).
Discussion
PA is now thought to be the most common potentially curable and specifically treatable form of hypertension [22] . So early diagnosis for PA is very important for improving the prognosis in clinic and accurate elucidation of the subtype is also essential for optimal treatment. But according to the Endocrine Society Guidelines, the definite diagnosis of PA is still comfied under recessive model (CC vs CT+TT, OR=0.522, 95%CI=0.296~0.919). As a consequence of this, all the genetic models produced significant association of T-344C polymorphism with IHA in the sensitivity analyses ( Table 2) . As all the studies in normotensive group were in HWE, and the essential hypertensive group as well as IHA group in China had only one study after excluding the studies not in HWE, sensitivity analysis was not performed. The association between A2718G polymorphism and PA under dominant model disappeared compared with that in primary analyses (Table  4) . IHA group had only one study for A2718G polymorphism after excluding the study by Guo et al. [20] , so the sensitivity analysis was not performed. , statistic to quantify the proportion of the total variation due to heterogeneity. PA, primary aldosteronism; APA, aldosterone-producing adenoma; IHA, idiopathic hyperaldosteronism; P h , P value of Q-test for heterogeneity test, random-effects model was used when P value for heterogeneity test <0.1, otherwise, fixed-effects model was used; I 2 , statistic to quantify the proportion of the total variation due to heterogeneity; NA, not available. with a mild, chronic and possibly gradual increase in ACTH over many years need to be more explored.
In contrast, there was no enough evidence to indicate the association of T-344C polymorphism with the occurrence of APA in our study. Moreover no genetic abnormality has been identified in gene coding regions of CYP11B2, the angiotensin II type 1 receptor ( AT1R ), or the tumor suppressor gene p53 in the patients with sporadic APA [30, 31] . The pathophysiology of APA remained an enigma until Choi et al [32] successfully identified somatic mutations (G151R and L168R) in the gene encoding the potassium channel KCNJ5 (also known as Kir 3.4 or GIRK4) in eight of 22 patients with APA. The frequency of these somatic mutations in 2 large unselected collections of adrenal aldosteronomas was determined as 41% [33] ( range from 12.5% [34] to 65.2% [35] , with the diversity probably related to differences in ethnicity, diagnostic strategies and patients selection for adrenalectomy ) . These KCNJ5 mutations, including the delI157 mutation [33] , found in the APA were located within either the selectivity filter itself or the adjacent inner vestibule of the ion channel [32] . These changes have been reported to cause increased sodium conductance and membrane depolarization resulting in the activation of voltage-gated Ca 2+ channels [32] . Then the resulting activation of CaMKI/IV (calcium/calmodulin-dependent protein kinase type I/IV) is followed by phosphorylation of ATF-1(activating transcription factor 1) and CREB (cAMP response element-binding protein) and transcriptional activation of NGFIB (nerve growth factor induced clone B) and NURR1 (Nur related factor 1), which in turn activate CYP11B2 promoter and finally increase aldosterone production [26, 36, 37] . However, it remains unclear whether and how KCNJ5 mutations are responsible for increased cell proliferation. Recently, Williams et al. reported that VSNL1 (Visinin-like 1) may play a key role in the development of KCNJ5 mutant APAs via its antiapoptotic function in response to calcium cytotoxicity and its effect on aldosterone production [38] . Besides, TDGF-1 (Teratocarcinoma-Derived Growth Factor-1) identified as a highly upregulated gene in APA may also assign a functional role in mediating increased aldosterone secretion and protecting cells from apoptosis through deregulation of the Akt signaling pathway [39] .
For the association between T-344C polymorphism and PA risk, the results from genetic models were controversial. This may be due to the opposite results of plex and must follow a rigorous flow-chart comprising screening, confirmation/exclusion testing and subtype diagnosis [4] . So it raises interesting questions about the different genetic basis of PA, hereafter genetic diagnosis can be used for faster and more accurate diagnosis of PA in future. There have been a number of published papers about the association of CYP11B2 gene polymorphisms with susceptibility to PA. So we conduct this meta-analysis to find whether CYP11B2 gene polymorphisms are related to PA and thus it can be a candidate gene to diagnosis PA.
To the best of our knowledge, it's the first time to perform a meta-analysis for the association of CYP11B2 polymorphisms with susceptibility to PA. As the genetic basis of familial hyperaldosteronism has been more clearly, it is not included in this meta-analysis.
Subgroup analyses based on type of PA, the results showed that the -344C allele might work as a potential protective factor for IHA to some extent. This results were in agreement with those of the study by Mulatero et al. [23] The-344C promoter allele is known to bind the SF-1 approximately five times more strongly than the -344T allele does [24] . Different with CYP11B1 strongly up-regulated by SF-1 through the Ad4 element, SF-1 has distinct effect on CYP11B2. It inhibited basal CYP11B2 promoter activity as well as activation by angiotensin II [24, 25] and the nuclear hormone receptors (NGFIB, NURR1) [26] in transfected human adrenocortical cells. Moreover, studies reported the overexpression of CYP11B2 mRNA in the lymphocytes of patients with IHA when compared to normal controls and APA subjects [27, 28] . This overexpression of CYP11B2 appeared to parallel the overproduction of aldosterone in the adrenal glands [28] and reinforces the hypothesis of a possible association of -344C allele with decreased IHA risk, at least partly, due to increased binding of SF-1. Besides, the study by Connell et al. found that basal and ACTH-stimulated plasma levels of 11-deoxycortisol, the precursor of cortisol, were higher in subjects carrying -344T allele [29] . The altered efficiency of conversion of 11-deoxycortisol to cortisol should lead to a mild but chronic increase in ACTH. It is clear that adrenal glomerulosa cells (both in vivo and in vitro) can acutely increase aldosterone production in response to ACTH but this effect declines after several days. However, from another perspective, patients with ACTH dependent Cushing's disease show major alteration neither in renin nor aldosterone levels in this circumstance. Thus the results of aldosterone synthesis IHA and APA.
The A2718G polymorphism (rs4539), which was found to be in strong linkage disequilibrium with T-344C [40] , has been proposed to be associated with low-renin essential hypertension in a Chilean population [41] . But the 2718G variant and 2718A wild-type had equivalent aldosterone synthase activities in transfected cells [41] . In the present study, we did not find any significant difference between the PA group and the control group in the genotypic distributions of the A2718G polymorphism according to the results of sensitivity analyses, although dominant model produced significant association between PA and A2718G polymorphism in the primary analyses. And for APA, no significant association was observed either in primary analyses or in sensitivity analyses. For IHA, despite the fact that there were two models had significant association, further study should be carried out to search for more significant evidence considering the limited sample size and one study not in HWE.
It is no doubt that there were some limitations in this meta-analysis due to sample size, genetic backgrounds and the uniformity of cases and controls. Though the heterogeneity was remarkably decreased by subgroup analyses, excluding the studies not fitting HWE in control population during sensitivity analysis and no publication bias was found during bias analysis, some defects of the current study should still be addressed. Firstly, some studies that were not in English or Chinese, as well as unpublished studies with negative results were not included in this meta-analysis. With limited published studies and small sample size, the reliability of our result still needs a set of more large-scale studies to confirm. Secondly, as the diagnosis of PA experienced a development process with the progress of medicine, the diagnostic methods of APA and IHA in the included studies were somewhat different and not all the studies used adrenal venous sampling(AVS), the current gold standard test for subtype classification of PA. So the misclassification of APA as IHA may possibly exist. Thirdly, the DNAs for genotyping on each study were different sourced. Some were extracted from peripheral blood, while others extracted from tissue samples. Fourthly, due to the limited study number and sample size, stratified analysis by country in IHA was restricted to Italy and China and it was not performed in APA. So it is critical that larger studies based on various countries are needed to search for more significant evidence. Fifthly, our results were based on unadjusted estimates. A more precise analysis should be performed if individual data were available, which would allow for the adjustment by covariates including age, gender, family history, environmental factors, and lifestyle.
Despite these limitations, this meta-analysis suggested that 344C allele may be associated with decreased risk of IHA and there was still no enough evidence to indicate the association of A2718G polymorphism with PA risk. Given the limited sample size, it is necessary to conduct a larger and comprehensive study to better understand the association between CYP11B2 polymorphisms and PA. In future, we hope to identify more genetic causes, develop biochemical markers to distinguish between APA and IHA, and determine the impact of genetic and environmental factors on aldosterone secretion in patients with and without PA [42] .
